United States
Germany
Japan
United Kingdom
China
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2B2 (formerly 2B2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Antibodies
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2D4 (formerly 2D4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI4B1 (formerly 4B1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2D2 (formerly 2D2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1A9 (formerly 1A9)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2F12 (formerly 2F12)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
活动过滤器
优化搜索结果
Category
Reactivities
Antibody Hosts
Conjugates
Clonalities
Brands
Families
Pathways
- Acute myeloid leukemia (55)
- B cell receptor signaling pathway (55)
- Bladder cancer (55)
- Chemokine signaling pathway (55)
- Chronic myeloid leukemia (55)
- Colorectal cancer (55)
- Dorso-ventral axis formation (55)
- Endometrial cancer (55)
- ErbB signaling pathway (55)
- Fc epsilon RI signaling pathway (55)
- Fc gamma R-mediated phagocytosis (55)
- Focal adhesion (55)
- Gap junction (55)
- Glioma (55)
- GnRH signaling pathway (55)
- Insulin signaling pathway (55)
- Long-term depression (55)
- Long-term potentiation (55)
- MAPK signaling pathway (55)
- Melanogenesis (55)
- Melanoma (55)
- Natural killer cell mediated cytotoxicity (55)
- Neurotrophin signaling pathway (55)
- Non-small cell lung cancer (55)
- Oocyte meiosis (55)
- Pancreatic cancer (55)
- Pathways in cancer (55)
- Prion diseases (55)
- Progesterone-mediated oocyte maturation (55)
- Prostate cancer (55)
- Regulation of actin cytoskeleton (55)
- Renal cell carcinoma (55)
- T cell receptor signaling pathway (55)
- Thyroid cancer (55)
- Toll-like receptor signaling pathway (55)
- VEGF signaling pathway (55)
- Vascular smooth muscle contraction (55)
